149 related articles for article (PubMed ID: 28698536)
21. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
[TBL] [Abstract][Full Text] [Related]
22. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
Koro CE; Bowlin SJ; Weiss SR
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
[TBL] [Abstract][Full Text] [Related]
23. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
24. Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin.
Berstein LM; Boyarkina MP; Teslenko SY
Med Oncol; 2012 Jun; 29(2):1308-13. PubMed ID: 21298495
[TBL] [Abstract][Full Text] [Related]
25. Metformin use and the risk of esophageal cancer in Barrett esophagus.
Agrawal S; Patel P; Agrawal A; Makhijani N; Markert R; Deidrich W
South Med J; 2014 Dec; 107(12):774-9. PubMed ID: 25502158
[TBL] [Abstract][Full Text] [Related]
26. Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer.
Henderson D; Frieson D; Zuber J; Solomon SS
Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
[TBL] [Abstract][Full Text] [Related]
27. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
[TBL] [Abstract][Full Text] [Related]
28. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
29. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
30. Metformin and the risk of head and neck cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
[TBL] [Abstract][Full Text] [Related]
31. Metformin Treatment and Cancer Risk: Cox Regression Analysis, With Time-Dependent Covariates, of 320,000 Persons With Incident Diabetes Mellitus.
Dankner R; Agay N; Olmer L; Murad H; Keinan Boker L; Balicer RD; Freedman LS
Am J Epidemiol; 2019 Oct; 188(10):1794-1800. PubMed ID: 31269196
[TBL] [Abstract][Full Text] [Related]
32. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.
Walker EA; Molitch M; Kramer MK; Kahn S; Ma Y; Edelstein S; Smith K; Johnson MK; Kitabchi A; Crandall J
Diabetes Care; 2006 Sep; 29(9):1997-2002. PubMed ID: 16936143
[TBL] [Abstract][Full Text] [Related]
33. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
Smiechowski BB; Azoulay L; Yin H; Pollak MN; Suissa S
Diabetes Care; 2013 Jan; 36(1):124-9. PubMed ID: 22923670
[TBL] [Abstract][Full Text] [Related]
34. Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study.
Ki YJ; Kim HJ; Kim MS; Park CM; Ko MJ; Seo YS; Moon SM; Choi JA
Cancer Res Treat; 2017 Jan; 49(1):29-36. PubMed ID: 27384155
[TBL] [Abstract][Full Text] [Related]
35. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.
Bowker SL; Lin M; Eurich DT; Johnson JA
Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558
[TBL] [Abstract][Full Text] [Related]
36. [Characterization of and costs associated to the profile of patients with type 2 diabetes treated with metformin who are added a second oral antidiabetic drug: a population study].
Sicras-Mainar A; Font-Ramos B; Roldán-Suárez C; Navarro-Artieda R; Ibáñez-Nolla J
Endocrinol Nutr; 2013 Dec; 60(10):557-69. PubMed ID: 24008167
[TBL] [Abstract][Full Text] [Related]
37. [Safety of metformin in the treatment of elderly type 2 diabetes mellitus].
Tian H; Li CL; Yang G; Wang YZ; Zong WY; Shao YH; Yan ST; Li J; Huang JH; Gong YP; Liu MY
Zhonghua Nei Ke Za Zhi; 2008 Nov; 47(11):914-8. PubMed ID: 19080232
[TBL] [Abstract][Full Text] [Related]
38. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting.
Geraldine N; Marc A; Carla T; Chantal M; Stefaan B; Welcome W; Frank B
Diabetes Res Clin Pract; 2012 Aug; 97(2):331-6. PubMed ID: 22386769
[TBL] [Abstract][Full Text] [Related]
39. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
Drzewoski J; Czupryniak L
Med Sci Monit; 2003 Jun; 9(6):CR240-3. PubMed ID: 12824953
[TBL] [Abstract][Full Text] [Related]
40. Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging.
Wennberg AMV; Hagen CE; Edwards K; Roberts RO; Machulda MM; Knopman DS; Petersen RC; Mielke MM
Int J Geriatr Psychiatry; 2018 Aug; 33(8):1114-1120. PubMed ID: 29873112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
